Moonlight Therapeutics

Biotechnology company developing innovative immunotherapy approaches for peanut allergy treatment, aiming to provide safer and more effective solutions for patients with severe food allergies.

Location
Atlanta, Georgia, USA
Founded
2021
Investors
1
Categories
biotech, allergy, immunotherapy, food-allergy, therapeutics

Notes

Moonlight Therapeutics is a biotechnology company focused on developing novel immunotherapy treatments for peanut allergy. The company is working to address the significant unmet need for safe and effective therapies for the millions of people living with potentially life-threatening peanut allergies.

Spun out of Texas Tech University, Moonlight Therapeutics is developing pre-clinical stage approaches that aim to desensitize the immune system to peanut allergens, potentially providing long-lasting protection against allergic reactions.

Team

Additional Research Findings

  • Founded in 2021
  • Headquarters in Atlanta, Georgia
  • Portfolio company of Portal Innovations
  • Pre-clinical stage development
  • University spinout from Texas Tech
  • Peanut allergy immunotherapy focus
  • Addressing ~2% of children with peanut allergy
  • Part of growing food allergy therapeutics sector

Sources

Investors

NameLocationTypeStagesPortfolio
Portal InnovationsUSbiotech-focused-13